Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Neoplasms 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Multiple Myeloma 2 Thyroid Neoplasms 1 Parathyroid Neoplasms 1 Osteoporotic Fractures 1 Osteoporosis 1 Osteopetrosis, mild autosomal recessive form 1 Osteopetrosis, Autosomal Recessive 7 1 Neoplastic Cells, Circulating 1 Musculoskeletal Pain 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Inflammatory Breast Neoplasms 1 Hypercalcemia 1 Humoral Hypercalcemia Of Malignancy 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Fractures, Bone 1 Endocrine Gland Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Ductal, Breast 1 Breast Diseases 1 Bone Diseases, Metabolic 1 Arthralgia 1

Interventions

Anastrozole 8 exemestane 7 Trastuzumab 7 Letrozole 7 palbociclib 6 Docetaxel 6 abemaciclib 5 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 Cyclophosphamide 4 Tamoxifen 3 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Denosumab × Breast × Clear all

NCT04711109 2025-04-02

BRCA-P

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡